市場調查報告書
商品編碼
1288649
全球近視和老花眼治療市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023至2030年預測Global Myopia and Presbyopia Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
據推測,到2030年,全球近視和老花眼治療市場的需求將從2022年的28.92億美元達到近77.78億美元,在2023-2030年的研究期間,複合年成長率為11.62%。
近視和老花是兩種需要治療的常見視力狀況。近視,也被稱為近視,是一種遠處的物體看起來很模糊的狀況。另一方面,老花眼是一種隨著人的年齡成長,眼睛逐漸失去聚焦於附近物體的能力的狀況。
由於生活習慣的改變和人口老齡化,近視和老花眼的發病率在全球範圍內不斷增加。這正在推動對有效治療方案的需求。新的手術技術、隱形眼鏡和藥品的發展正在推動市場的成長。患者和醫療機構對現有的近視和老花眼的治療方案的認知越來越多。這促使了對治療方案的更大需求,推動了市場的成長。在治療近視和老花眼方面,微創手術的需求量很大。這是由於這種手術的好處,包括更快的恢復時間和減少併發症的風險。醫療保健支出的增加,特別是在新興經濟體,正在推動近視和老花眼治療市場的成長。隨著這些國家的醫療系統不斷擴大和改善,更多的患者獲得了治療方案。
該研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地了解行業結構,並在全球範圍內評估競爭的吸引力。此外,這些工具還對全球近視和老花眼治療市場的每個細分市場進行了全面評估。近視和老花眼治療行業的成長和趨勢為這項研究提供了一個全面的方法。
本節涵蓋了區域前景,強調了北美、歐洲、亞太、拉美、中東和非洲的近視和老花眼治療市場的當前和未來需求。此外,該報告重點關注所有突出地區的個別應用部門的需求、估計和預測。
該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。近視和老花眼治療市場的主要參與者包括Ziemer Ophthalmic Systems AG, NIDEK CO.LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated., Carl Zeiss AG, Orasis Pharmaceuticals, Regeneron Pharmaceuticals Inc., Haag-Streit UK, Topcon Corporation, AbbVie, Sydnexis, The Cooper Companies Inc.這一部分包括對競爭格局的整體看法,其中包括各種戰略發展,如主要的合併和收購、未來的能力、夥伴關係、財務概況、合作、新產品的開發、新產品的推出以及其他發展。
注意- 在公司簡介中,財務細節和最近的發展情況要視情況而定,如果是私營公司,可能不包括在內。
The global demand for Myopia and Presbyopia Treatment Market is presumed to reach the market size of nearly USD 77.78 BN by 2030 from USD 28.92 BN in 2022 with a CAGR of 11.62% under the study period 2023-2030.
Myopia and presbyopia are two common vision conditions that require treatment. Myopia, also known as nearsightedness, is a condition in which objects that far away appear blurry. Presbyopia, on the other hand, is a condition in which the eye gradually loses its ability to focus on nearby objects as a person ages.
The prevalence of myopia and presbyopia is increasing worldwide due to changing lifestyle habits and an ageing population. This is driving the demand for effective treatment options. The development of new surgical techniques, contact lenses, and pharmaceuticals is driving the growth of the market. There is a growing awareness among patients and healthcare providers about the available treatment options for myopia and presbyopia. This is leading to greater demand for treatment options and driving the growth of the market. Minimally invasive procedures are in demand for the treatment of myopia and presbyopia. This is due to the benefits of such procedures, including faster recovery times and reduced risk of complications. The increasing healthcare expenditure, particularly in emerging economies, is driving the growth of myopia and presbyopia treatment market. As healthcare systems continue to expand and improve in these countries, more patients are gaining access to treatment options.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of myopia and presbyopia treatment. The growth and trends of myopia and presbyopia treatment industry provide a holistic approach to this study.
This section of the myopia and presbyopia treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Myopia and Presbyopia Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the myopia and presbyopia treatment market include Ziemer Ophthalmic Systems AG, NIDEK CO. LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated., Carl Zeiss AG, Orasis Pharmaceuticals, Regeneron Pharmaceuticals Inc., Haag-Streit UK, Topcon Corporation, AbbVie, Sydnexis, The Cooper Companies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.